Cargando…

Pathological changes in platelet histamine oxidases in atopic eczema

Increased plasma histamine levels were associated with significantly lowered diamine and type B monoamine oxidase activities in platelet-rich plasma of atopic eczema (AE) patients. The diamine oxidase has almost normal cofactor levels (pyridoxal phosphate and Cu(2+)) but the cofactor levels for type...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiehl, Reinhold, Ionescu, Gruia
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365432/
https://www.ncbi.nlm.nih.gov/pubmed/18475554
http://dx.doi.org/10.1155/S0962935193000560
_version_ 1782154167111909376
author Kiehl, Reinhold
Ionescu, Gruia
author_facet Kiehl, Reinhold
Ionescu, Gruia
author_sort Kiehl, Reinhold
collection PubMed
description Increased plasma histamine levels were associated with significantly lowered diamine and type B monoamine oxidase activities in platelet-rich plasma of atopic eczema (AE) patients. The diamine oxidase has almost normal cofactor levels (pyridoxal phosphate and Cu(2+)) but the cofactor levels for type B monoamine oxidase (flavin adenine dinucleotide and Fe(2+)) are lowered. The biogenic amines putrescine, cadaverine, spermidine, spermine, tyramine and serotonin in the sera, as well as dopamine and epinephrine in EDTA-plasma were found to be normal. It is unlikely, therefore, that these amines are responsible for the decreased activities of monoamine and diamine oxidase in these patients. The most likely causative factors for the inhibition of the diamine oxidase are nicotine, alcohol, food additives and other environmental chemicals, or perhaps a genetic defect of the diamine oxidase.
format Text
id pubmed-2365432
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23654322008-05-12 Pathological changes in platelet histamine oxidases in atopic eczema Kiehl, Reinhold Ionescu, Gruia Mediators Inflamm Research Article Increased plasma histamine levels were associated with significantly lowered diamine and type B monoamine oxidase activities in platelet-rich plasma of atopic eczema (AE) patients. The diamine oxidase has almost normal cofactor levels (pyridoxal phosphate and Cu(2+)) but the cofactor levels for type B monoamine oxidase (flavin adenine dinucleotide and Fe(2+)) are lowered. The biogenic amines putrescine, cadaverine, spermidine, spermine, tyramine and serotonin in the sera, as well as dopamine and epinephrine in EDTA-plasma were found to be normal. It is unlikely, therefore, that these amines are responsible for the decreased activities of monoamine and diamine oxidase in these patients. The most likely causative factors for the inhibition of the diamine oxidase are nicotine, alcohol, food additives and other environmental chemicals, or perhaps a genetic defect of the diamine oxidase. Hindawi Publishing Corporation 1993 /pmc/articles/PMC2365432/ /pubmed/18475554 http://dx.doi.org/10.1155/S0962935193000560 Text en Copyright © 1993 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kiehl, Reinhold
Ionescu, Gruia
Pathological changes in platelet histamine oxidases in atopic eczema
title Pathological changes in platelet histamine oxidases in atopic eczema
title_full Pathological changes in platelet histamine oxidases in atopic eczema
title_fullStr Pathological changes in platelet histamine oxidases in atopic eczema
title_full_unstemmed Pathological changes in platelet histamine oxidases in atopic eczema
title_short Pathological changes in platelet histamine oxidases in atopic eczema
title_sort pathological changes in platelet histamine oxidases in atopic eczema
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365432/
https://www.ncbi.nlm.nih.gov/pubmed/18475554
http://dx.doi.org/10.1155/S0962935193000560
work_keys_str_mv AT kiehlreinhold pathologicalchangesinplatelethistamineoxidasesinatopiceczema
AT ionescugruia pathologicalchangesinplatelethistamineoxidasesinatopiceczema